A2: Post-Pfizer Business

By

The Motley Fool reports on a growing number of contract research organizations that have emerged in the wake of Pfizer closing its Ann Arbor research operation. The article quotes Bill Sibold, CEO of Plymouth-based Lycera: “There is this resource now in Michigan where you can draw on the expertise of the former Pfizer/Parke-Davis. People don’t think Michigan has this capability, but Michigan does have the capability.” [Source]